Study: No higher cancer rate at Conn. Pratt plant

by Stephen Singer

(AP)—Researchers examining the incidence of brain cancer at jet engine manufacturer Pratt & Whitney in Connecticut say they have found no statistically significant elevations in the rate of cancer among workers.

The researchers at the University of Pittsburgh and the University of Illinois at Chicago said Thursday they identified 723 workers diagnosed with tumors between 1976 and 2004 at the United Technologies Corp. subsidiary. The tumors were malignant, benign or unspecified and included 277 cases of .

The researchers also reviewed 11 chemical or physical agents on the basis of known or suspected carcinogenic potential that could affect the central nervous system or other organs.

The results end an 11-year, $12 million study commissioned by Pratt & Whitney and overseen by the state Department of Public Health.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

United Technologies CEO sees sequester impact

Feb 21, 2013

(AP)—The chief executive of United Technologies expects automatic federal budget cuts will take effect in eight days, cutting slightly into earnings of the aerospace giant.

China denies using stolen US copter technology

Jul 26, 2012

(AP) — Allegations that China used stolen U.S. technology to develop a modern military attack helicopter were "severe deviations" from the facts, the Chinese Defense Ministry said Thursday.

United Tech sees sales rising with Goodrich buy

Dec 13, 2012

United Technologies Corp. says its purchase of aircrafts parts maker Goodrich Corp. will drive revenue growth next year, helping overcome Europe's weak economy and less U.S. defense spending.

Recommended for you

The fine line between breast cancer and normal tissues

1 hour ago

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham ...

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

2 hours ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Good bowel cleansing is key for high-quality colonoscopy

4 hours ago

The success of a colonoscopy is closely linked to good bowel preparation, with poor bowel prep often resulting in missed precancerous lesions, according to new consensus guidelines released by the U.S. Multi-Society Task ...

New rules for anticancer vaccines

6 hours ago

Scientists have found a way to find the proverbial needle in the cancer antigen haystack, according to a report published in The Journal of Experimental Medicine.

User comments